13D/13G Filings - Lexeo Therapeutics Inc. (LXEO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-12-11
5:13 pm
Purchase
2023-11-30 13G Lexeo Therapeutics, Inc. Common Stock
LXEO
Eventide Asset Management, LLC 3,002,831
11.930%
3,002,831increase
(New Position)
Filing
History
2023-11-24
4:33 pm
Purchase
2023-11-15 13G Lexeo Therapeutics, Inc. Common Stock
LXEO
Novo Holdings A/S 1,294,053
5.100%
1,294,053increase
(New Position)
Filing
History
2023-11-17
4:23 pm
Purchase
2023-11-07 13G Lexeo Therapeutics, Inc. Common Stock
LXEO
Citadel Advisors LLC 2,092,488
8.300%
2,092,488increase
(New Position)
Filing
History
Goto Prev, 0, 1